Pfizer CEO Says They Found More Than 50 Fake Drugs Just Last Year

In light of the  fake Avastin scandal, many are now wondering exactly how many counterfeit medications are on the market today.  According to an interview with The Financial Times, one CEO says that the problem is much more wide spread than one would think.

Pfizer CEO Ian Read said the company confirmed more than 50 fakes of its drugs in at least 101 countries just last year.

An investigation by The Wall Street Journal reported that in 2010, fake Avastin was found in Shanghai and in Syria a year earlier. The issue has again prompted discussions of whether unique labeling or other procedures are needed to protect against counterfeits, which can be useless and deadly. Counterfeits have been more of a problem in developing countries that have less stringent oversight. But with the money that can be made, there are fears more fakes will start showing up in places like the U.S. and Europe.

Bill Donnelly, Pfizer’s chief of anti-counterfeiting for North America said that

“Outlaw pill makers usually want to make sure they work well enough to keep users coming back but take risks with health.”

“They are more likely to put too much active ingredient,” said Donnelly, a retired FBI agent. “If it works too well, people will buy it again.”  And that is the risk, he said.

“The problem is you don’t know how these things are manufactured,” he said. “They are potentially putting their lives in danger because they really don’t know where these things are coming from.”

Pfizer, which works internationally with law-enforcement to uncover as well as prosecute cases of counterfeiting, said it has tested seized pills that contained wallboard or been colored by the same paint used on highways.

“Another thing with counterfeits is they are often manufactured in places where you wouldn’t even want to walk around,” Donnelly said. “Some of these places are filthy.”

About 8.3 million fake Pfizer tablets were seized worldwide in 2010, according to the company, and 57 percent of those were copies of Viagra.

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Paxil Possibly Linked To Breast Cancer Risk

Cancer researchers from the City of Hope National Medical Center announced a possible link between Paxil and breast cancer. Research focused on Paxil’s estrogen effect Researchers found that Paxil has a weak estrogen effect that could increase women’s breast cancer risks. According to lead author and chairman of City of Hope’s Department of Cancer and […]

Big Pharma under Fire for Kickbacks to Docs

Trust and honesty are the cornerstones to a doctor-patient relationship. With so many doctors receiving financial incentives to use certain medications or medical devices, patients need to know if money drives the decision making process. Doctors are required to disclose potential financial conflicts to each other at conferences, but there currently is no law forcing […]

Dietary Supplements Damage Liver

A recent study revealed a significant increase in liver damage related to dietary supplements. The study, conducted by a national network of liver specialists, found a 13% increase in serious liver damage over a 10 year span. Some of these patients required liver transplants and some have even died due to liver failure. Authors of […]

FDA Advisory Committee Supports Approval of Gilead’s HIV Reducing Drug

The pharmaceutical industry may be on the verge of one of the greatest breakthrough’s that this generation has ever seen.

U.S. Health Regulators Issue New Restrictions For Gilenya, Novartis AG’s’ Multiple Sclerosis Pill

In December 2011, the FDA issued a Drug Safety Communication concerning a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod).

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.